Document is current
Any future updates will be listed below
-
Authors
Li, Xin
Wang, Chenjing
Shi, Ping
Liu, Yanping
Tao, Ye
Lin, Pingping
Li, Ting
Hu, Haixun
Sun, Feifei
Liu, Shuqin
Fu, Yao
- License Information
-
More Information
Article History
Received: 26 June 2022
Accepted: 13 February 2023
First Online: 3 March 2023
Declarations
:
: The trial was performed abiding by the Declaration of Helsinki [CitationRef removed], Good clinical practice (GCP) [CitationRef removed] and the guidelines of China National Medical Products Administration (NMPA). The protocol, informed consent and other relevant documents were independently approved by the Medical Ethics Committee of the Affiliated Hospital of Qingdao University and were numbered QYFYEC 2020–018-01. Any deviation or violation of the protocol during the trial overshoot has been reported to the ethics committee. Before the study, all subjects were informed of the purpose, process, benefits and risks of the study and voluntarily signed informed consent. The study adheres to CONSORT guidelines and include a completed CONSORT checklist as an InternalRef removed.
: Not applicable.
: The authors report no conflicts of interest.
